The National Hemophilia Foundation’s (NHF's) Medical and Scientific Advisory Council (MASAC) issued the following three new documents, which were adopted by NHF’s Board of Directors on February 28, 2016:
MASAC Document #239 includes specific recommendations concerning hepatocellular cancer (HCC) screening in patients with hemophilia, cirrhosis and hepatitis C.
View and download MASAC Recommendations on Screening for Development of Hepatocellular Cancer in Patients with Hepatitis C.
MASAC Document #240 contains the council’s most recent series of treatment recommendations, including information on currently available therapies.
View and download MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders.
MASAC Document #241 includes general recommendations relevant to the use of prophylaxis in patients with hemophilia A and B.
View and download MASAC Recommendation Concerning Prophylaxis.
View the complete list of current MASAC documents. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center: handi@hemophilia.org (link sends email) or 1.800.424.2634.
